American Cancer Society a Danger to Science?

The credibility of the peer review process has come under vehement attack.  Scientists who receive no-strings-attached financial support for their research from demonized industries – tobacco, pharmaceuticals, and food, among others – are no longer deemed trustworthy.

Apparently, the rigors of the peer review process – even in the world’s best science and medical journals – in addition to full disclosure requirements, isn’t enough to prevent “biased” studies from being published.  Activists – displeased with results that undermine their agenda – cry bias, and prestigious science and health organizations cave, preferring to appease the advocates, rather than allow the scientific method to weed out bad science.

One of the country’s most distinguished cancer organizations has succumbed to the prohibitionist faction of the anti-tobacco movement’s demagogic rhetoric.  Accepting and adopting these crusaders’ guilt-by-association arguments at face value, rather than identifying flaws in the research results they oppose.

Earlier this year, the American Cancer Society (ACS) passed a resolution barring scientists who receive financial support from the tobacco industry from receiving ACS grants.  Responding to news of the resolution, Dr. Elizabeth Whelan warned ACS (see letter below) against their injurious adoption of such a litmus test.  Using funding as a basis for rejection is detrimental to the process of providing unbiased, peer-reviewed health information.

Such policies have unseen costs and unintended consequences.  They may produce biased research by cherry-picking authors and results and confusing public debate – mirroring the tobacco industry’s stratagem.  Further, they set a dangerous precedent by giving opponents of sound science a new weapon.  If the science is faulty, we should use science itself, not ad hominem or innuendo, to detect the problems.

ACS’s response to our criticsm?  Six months later, we’re still waiting.  Regardless of whether we ever receive a reply, we hope ACS got the message. Putting science ahead of ideology is best for cancer patients as well as the general public, who rely on good science – that which is able to survive the rigors of peer review – not simply good intentions.

 

USA Today: “Plant foods to the rescue”

Scientists who study nutrition paint a very different picture.

A growing body of research shows that, once inside the body, fruits and vegetables spring into the role of superheroes, fighting cancer and other diseases in at least eight simultaneous ways. And, like the Superfriends, they seem to work better as a team. Some phytochemicals, or plant chemicals, knock out carcinogens and fight inflammation. Some regulate how quickly cells reproduce and spur old, damaged cells to self-destruct. Other plant chemicals perform “routine maintenance” on DNA, says Jeff Prince, vice president for education at the Washington-based American Institute for Cancer Research.

Doctors caution that recent research indicates that fruits and vegetables may not provide as much protection against cancer as once believed. In the past five years, studies have shown that weight control may be more crucial, says Walt Willett, chairman of the nutrition department at the Harvard School of Public Health.

Yet most experts agree that the body needs a variety of these phytochemicals – there are more than 25,000 of them – to stay in top form. That’s why so many nutritionists no longer stress individual “power foods,” Prince says, but instead promote a “plant-based” diet of fruits, vegetables, whole grains, beans and nuts. Preliminary research indicates these foods bring out the best in each other and magnify their protective effects.

At the cancer institute’s annual scientific conference in July, researchers from the University of Illinois-Urbana described their research feeding tomatoes and broccoli to lab rats that had prostate cancer. The tumors of rats that were fed both vegetables shrank far more than those of animals who ate either food alone. Researchers stressed, though, that people do not necessarily react the same way as animals and that many larger studies need to be done to confirm these results.

“The take-home message is not that experts recommend tomatoes and broccoli,” Prince said at the conference. “We’re not going to find a single source that fights disease. What’s important is the interaction of thousands of plant chemicals.” Humans evolved to depend on a rich diet of 800 plant foods, says David Heber, director of the University of California-Los Angeles Center for Human Nutrition. Today, he says, most people eat three, and those are often french fries, ketchup and iceberg lettuce.

Yet some potentially potent plant foods, experts say, are exotic varieties that Americans rarely sample: herbs such as ginseng; spices such as turmeric, used in Indian cooking; and Reishi and Maitake mushrooms from Japan. Heber suggests that people select their five to nine recommended daily servings of fruits and vegetables from seven color groups, such as purple grapes or yellow squash, whose colors are produced by disease-fighting chemicals called carotenoids.

Scientists have identified only a handful of the thousands of potentially beneficial plant chemicals, says Daniel Nixon, author of The Prostate Health Program and president of the Institute for Cancer Prevention in New York. People who would rather pop dietary supplements instead of eating the real thing may miss out on proven health promoters such as fiber, as well as compounds that scientists have yet to discover, Nixon says. Last week, the American Heart Association published an advisory finding that antioxidant supplements do not prevent heart disease. In some studies, supplements with beta carotene – the chemical that colors carrots orange – increased the risk of cancer.

Plants vs. disease

Plant foods, however, may help prevent a number of diseases, says Rachel Brandeis of the American Dietetic Association. Antioxidants found in vegetables neutralize dangerous molecules called “free radicals,” which are produced by smoking and radiation, as well as everyday activities of the body. Left to themselves, free radicals attack healthy cells and may lead to plaques in the arteries and even Alzheimer’s. They also can damage DNA in ways that lead to cancer. As plants evolved, they developed antioxidants to fight free radicals, Heber says. Humans grew to depend on fruits, vegetables and nuts to provide these vital defenses. That may explain why, without a rich plant diet, people are more vulnerable to disease. Diets rich in plant compounds, on the other hand, may prevent a variety of ailments.

At a meeting of the Alzheimer’s Association last month, for example, researchers presented the results of a six-year study of 3,000 senior citizens. In the study, people who consumed lots of vitamin C and carotenoids, both through food and supplements, scored higher on reasoning tests. Carotenoids are found in squash, strawberries and other fruits. According to another study presented at the meeting, vegetables such as spinach and broccoli – which contain vitamin C and carotenoids, as well as the vitamin folic acid – were found to slow cognitive decline.

Other things that appear to lower the risk of Alzheimer’s include vitamin E, found in wheat germ, and fatty fish, such as salmon and mackerel, which are rich in omega-3 fatty acids, according to the Alzheimer’s Association. Scientists say they still have many questions about antioxidants: Can they fight cancer at any stage of the disease or at any age? Or do people benefit only if they consume these foods from infancy? Under which circumstances might antioxidants promote disease, rather than healing?

Scientists have identified at least a handful of the ways that plant foods appear to fight disease, says Cheryl Rock, a professor of nutrition at the University of California-San Diego Cancer Center. * By mopping up free radicals, antioxidants such as the beta carotene in sweet potatoes or the vitamin E in almonds prevent cell damage. Another class of chemicals called flavonoids have been shown to activate the body’s natural DNA repair system.

* Fruits and vegetables often are high in potassium, which can help control blood pressure.

* Antioxidants may interrupt a process leading to inflammation, which appears to play a role in cardiovascular disease and cancer. Vitamin B6, found in bananas, and folic acid, found in broccoli and leafy greens, both lower levels of homocysteine, which has been linked to hardening of the arteries, heart attacks, strokes and dementia.

* Chemicals such as beta carotene also help regulate the natural cycle of cell birth and death, telling cells when to divide, differentiate into new types or recycle themselves. Keeping this process under tight control can prevent cancer, Rock says.

* Phytochemicals in foods such as Brussels sprouts, red cabbage and kale may help prevent cancer by activating enzymes that break down carcinogens.

Antioxidants vs. angiogenesis

* Emerging research suggests that antioxidants may shut down a process called angiogenesis, by which tumors recruit blood supplies that help them grow and spread, says William Li, president of the Angiogenesis Foundation. Scientists are investigating links between angiogenesis and compounds found in foods such as licorice, blueberries and garlic, Li says.

Researchers who studied tumors in mice were able to cut back the number of new blood vessels by 70% simply by replacing their water with green tea, Li says. Scientists have not proved this link in humans.

* Plant foods such as whole-grain cereals and oats are loaded with fiber. In a study of 40,000 male health professionals, high-fiber diets reduced the risk of coronary heart disease by 40%. Diets filled with cereal fiber also may help prevent diabetes and a painful intestinal inflammation called diverticular disease. “Mother Nature is cleverer than all of us and has laced many of our favorite foods with things that can be helpful,” Li says. “Ancient cultures have long recognized that your diet can be healing, and
scientists are only now beginning to understand why.” Digest the benefits of this basket of foods

Many nutritionists today stress the importance of healthy dietary patterns – ones filled with vegetables, fruits, whole grains, beans, nuts and lean proteins – combined with regular exercise and weight control. Though no one food is a “magic bullet,” some experts encourage people to include foods such as these in their diets.

Digest the benefits of this basket of foods

Many nutritionists today stress the importance of healthy dietary patterns ones filled with vegetables, fruits, whole grains, beans, nuts and lean proteins – combined with regular exercise and weight control. Though no one food is a “magic bullet,” some experts encourage people to include foods such as these in their diets. Tomatoes The carotenoid lycopene. Eating several servings a week may reduce the risk of prostate cancer up to 35% and also may reduce the risk of heart attack and stroke. To get the most lycopene, cook tomatoes with a little “healthful” fat, such as olive oil.

Whole-grain breads and cereals Fiber and antioxidants. May lower the risk of heart disease by 40%. May also help prevent diabetes. Read labels to make sure that the first ingredient in the bread says whole wheat, not just wheat or “stone-ground wheat.” Salmon, mackeral, sardines Omega-3 fatty acids. Reduces risk of heart disease, diabetes and possibly Alzheimer’s and cancer. Reduces inflammation, which may help prevent or relieve symptoms of arthritis. Contains vitamin D, which builds strong bones and may protect against colon cancer. Cooked, to kill microorganisms and parasites. Broiled, to eliminate contaminants found in freshwater fish. For canned fish, serve with the soft, mashed, calcium-rich bones.

Spinach and other leafy greens Folic acid. This may reduce risk of birth defects, heart attack, Alzheimer’s, depression and inflammation. Folic acid also reduces the risk of fractures. Potassium lowers blood pressure and the danger of strokes. The carotenoids lutein and zeaxanthin may help fight age-related eye disease. Antioxidants called flavones may reduce breast cancer risk.  Fresh or lightly steamed to preserve vitamin C; with nuts, olive oil or avocados, whose fat helps to increase absorption of antioxidants.

Blueberries or other berries Antioxidants such as vitamin C. These may reduce risk of heart disease, cancer, mental decline and other diseases of aging. May help prevent urinary-tract infections by inhibiting bacteria.  Fresh, raw or lightly cooked. Wash them just before serving to avoid mold and bruising. Canning blueberries removes half of the vitamin C. Sweet potatoes Carotenoids, which may help reduce the risk of Alzheimer’s. Beta carotene also may lower the risk of cancers of the larynx, esophagus and lungs. Baked or boiled.

 

NEW VERSION OF TEST FOR CANCER-CAUSING AGENTS NEEDS NO ANIMALS

A new version of a popular test for cancer-causing agents is cheaper, more sensitive and, best of all, animal-free, thanks to a U of G researcher. Prof. David Josephy, Chemistry and Biochemistry, has developed a way of testing substances for cancer-causing potential without using animal tissue. Instead, his version of the Ames test involves gene splicing.

“Nobody has figured a way around using animals until now,” says Josephy. “We hope that no more animals will have to die for the sake of the Ames test.” Two decades ago, the Ames test (named after inventor Bruce Ames, a bacterial geneticist from the University of California at Berkeley) was heralded as a breakthrough in cancer research. Ames’s goal was to eliminate the use of animals in tests for cancer-causing or “mutagenic” agents.

In his efforts to put an end to animal use, Ames came up with a way to use animal tissue for his tests, rather than the whole animal. In animals, cancer-causing agents are inactive until they’re chemically changed or “metabolized” by certain enzymes. When they’re changed, they become dangerous because they’re converted into different forms of chemicals.

Ames chose rodent liver extracts for his test because the liver contains more metabolic enzymes than other organs do. In a test tube, he combined liver cells and bacteria. He used bacteria because they’re so small that billions of cells can be affected by the mutagen in one test, making results easier to observe. When a potential cancer-causing agent is introduced into the test tube, it’s metabolized by the enzymes in the liver and causes DNA damage or mutations to the bacterial cells. DNA damage mutates cells, which results in cancer in animals.

The test has enabled researchers to identify carcinogens such as the charring on burnt food and a chemical used to fireproof children’s pyjamas, which was banned after the discovery was made. The Ames test used only a portion of a rodent’s liver. That meant it reduced the use of animals needed to detect suspected mutagens because one liver provided enough material for hundreds of tests. With the Ames test, mutagen-detection laboratories need to use only a few dozen rodent livers each year instead of the thousands of animals that lifetime feeding tests would require.

Now Josephy has taken that a step further. He has completely eliminated the need for animals to be involved. In the last few years, researchers have identified the gene — called P4501A2 — that makes the enzyme needed to metabolize carcinogens so they become mutagenic. Different enzymes metabolize different carcinogens; the enzyme P4501A2 metabolizes one class of compounds called aromatic amines, the carcinogens in charred material.

Josephy spliced the P4501A2 gene into the bacterial cell responsible for producing the metabolizing enzyme that identifies it as a mutagen. By splicing the gene into the bacteria, he’s made it possible for the bacteria to produce the required enzyme, so that no rat liver is needed. As a result, when potential mutagenic chemicals are introduced, the bacteria are a complete mutagen-detecting package  in themselves.

Josephy has installed a clone of the human P4501A2 gene into the bacteria to make the test even more representative of human metabolism. The cloned human genes come from Peter Guengerich, a collaborator at the Vanderbilt University School of Medicine in Nashville. “It means we can do a much more sophisticated mutagen analysis than we could in the past,” says Josephy. “We’re fulfilling Ames’s goal.” This work is sponsored by the National Cancer Institute of Canada and the Natural Sciences and Engineering Research Council.

 

Male breast cancers ‘more common’

More men are developing breast cancer – but most fail to spot tumours until they are at an advanced stage, a study has warned. University of Texas research found that, while men are far less likely to develop breast tumours than women, the numbers are increasing. Writing in an online edition of the journal Cancer, they warn men seem to be unaware they can develop the cancer.

UK experts said the cancer was rare, but men should be aware of changes. It is important to visit your GP straight away if you notice any change in your body that is not normal Henry Scowcroft, Cancer Research UK The researchers looked at a National Cancer Institute data on cancer incidence and survival in the US from 1973 to 1998. They found that, over the last 20 years, the incidence of male breast cancer had increased from 0.86 to 1.08 per 100,000 men. They then examined 2,524 cases of male breast cancer and 380,856 cases of female breast cancer on the database, diagnosed over that period. The researchers found that compared to female patients, men tended to be significantly older when they were diagnosed – 67 years versus 62 years of age.

They were also more likely to have later stage disease and had more spread of the cancer to their lymph nodes. ‘Easier to spot’ Professor Sharon Giordano, who led the research, said: “Male breast cancer is rare, accounting for less than one per cent of all breast cancer. “But she said: “Men should be alert to the possibility that the disease could affect them.” Professor Giordano added: “It’s perhaps ironic that tumours in men are easier to feel than they are in women, yet the disease is being discovered at a later stage in men than in women.” The researchers say that part of the reason for late diagnosis may be that men assume they are experiencing a benign condition called gynecomastia, or breast tissue growth, that affects about a third of males at some point in their lives.

The condition, which is common in teenage boys, can come and go over a man’s lifetime. Professor Giordano said: “Men may think new growth of breast tissue is just another occurrence of this condition.” The team also found that men often had more larger tumours which had spread further and more aggressive forms of cancer when they were diagnosed.However, survival rates for men and women were no different. The researchers said men were more likely than women to have oestrogen-positive tumours. Professor Giordano: “We are not sure why this is so, but it may indicate some important differences in tumour biology.”In addition, this implies that use of tamoxifen in men may be as beneficial as it is to many women.” She added: “Now that we have a clearer understanding of the biology of breast cancer in men, further research is needed to determine the optimal treatment for men.”

‘Campaigns aimed at women’

Henry Scowcroft, Science Information Officer at Cancer Research UK said: “Breast cancer is very rare among UK men, and when it does occur, it tends to do so between the ages of 60 and 70.”Only about 300 men are diagnosed with the disease each year, compared with about 41,000 new cases in women. Because of this, most breast cancer awareness campaigns are aimed at women. “While Cancer Research UK does not recommend that men, especially young men, examine themselves regularly, it is important to visit your GP straight away if you notice any change in your body that is not
normal.”

 

US-CA, An Associate Scientist in Cell Biology, Cancer Research

COMPANY
Well-equipped U.S. research headquarters of international drug discovery company. Attractive campus. Excellent resources. High caliber of science. Company is committed to cutting edge research. Provides cutting-edge tools and support. Highly collaborative environment.

DESCRIPTION
Cell biology associate scientist for a cancer research group heavily focused on breast cancer. Apply 3 to 5 years of relevant experience ideally acquired within an industrial biotech environment.

RESPONSIBILITIES
Within a cell biology department, support cancer research genomics program focused on breast cancer. Apply knowledge in cell biology, cell based assays, cell-cell and cell-matrix signaling mechanisms, and antibody experience. Develop, optimize and perform cell-based assays to evaluate novel-gene therapeutic candidates. Validate novel protein drug targets utilizing strategies such as neutralizing antibodies and anti-sense oligonucleotide-based gene knock-outs. Another validation method used will be transfections of wild-type and dominant negative protein.

LOCATION
San Francisco Bay Area.
QUALIFICATIONS
BS or MS in cell biology with 3 to 5 years of pertinent experience, ideally within an industrial biotech setting. Broad knowledge of cell biology. Cell based assay experience (ex: proliferation, apoptosis, migrations and/or invasion assays). Experience working with cancer cell lines. The ability to manipulate a cell is important. Two crucial areas of technical knowledge are: 1.) Mammalian cell transfection and 2.) Delivering antisense oligonucleotides. Ideally we are seeking experience in the culture and transfection of primary and established human cell lines. Strong interpersonal and problem solving skills also important..

DESIRED (Not Mandatory)
Possible growth factor experience. Extracellular matrix interaction. Familiarity with: DNA expression vectors. Antisense olignucleotides. Immuno-cytochemistry and antibody characterization. Molecular biology techniques: such as cDNA cloning, DNA and RNA isolation. Northern and Western blot analysis.

COMPENSATION
Competitive salary and benefits.

 

Postage Stamp to Raise Money for Cancer Research

LOS ANGELES- the Postal Service unveiled the design of the Breast Cancer Research “Semipostal” Stamp, here, at the Revlon Run and Walk for Women on May 9th. A nationwide issuance of this  self-adhesive stamp begins in early August.

As a 40 cent “semipostal,” the Breast Cancer Research stamp will be deemed valid for postage at the prevailing First Class Rate, currently 32 cents, with the extra 8 cents going to fund medical research at the National Institutes of Health (70 percent) and Department of Defense (30 percent).

The background of the vertically formatted stamp design features blue,yellow, orange, and green washes of watercolor.  Along the top are the words, “breast cancer” in capital letters.  A black ink drawing of a female figure is the main element, while the phrases “fund the fight” and “find a cure” appear in capital letters flowing left to right into a clockwise, circular pattern.

The stamp was designed by Ethel Kessler, a breast cancer survivor, of Bethesda, MD, and illustrated by Whitney Sherman of Baltimore, MD. This is the first time in history that the U.S. Postal Service has issued a “semipostal” stamp.  It took an act of Congress after “grass roots” campaigning by several groups led by Dr. Ernie Bodai of Sacramento, CA, to get this unique postage stamp issued.

Among the thousands at the unveiling ceremony, was Mercy Davidchik of Yuba City, CA, who was one of the most active volunteer workers in raising public support and promoting legislation to issue the Breast Cancer Research Stamp.   It is hoped that through purchase of these stamps, millions of dollars will be raised for breast cancer research, which  is considered the most commonly diagnosed cancer among all women in the U.S.

 

Breast Cancer Research Semi-postal Stamps

Breast Cancer Research Semi-postal Stamps are subject to special limitations and conditions:
    a. Breast Cancer Research Semi-postal Stamps provide a means for customers to make contributions toward breast cancer research. Breast Cancer Research Semi-postal Stamps are offered for sale for a limited time as provided under 39 U.S.C. 414.
    b. The price of the Breast Cancer Research Semi-postal Stamp is 40 cents. The postage value of the Breast Cancer Research Semi-postal Stamp is the First-Class Mail Non automation Single-Piece first-ounce letter rate in R100.1.2 that is in effect at the time of purchase. The difference between the purchase price and the First-Class Mail Non automation Single-Piece first-ounce letter rate in effect at the time of purchase constitutes a contribution to breast cancer research, and cannot be used to pay postage. Additional postage must be affixed to pieces weighing in excess of one ounce, pieces subject to the nonstandard surcharge, or pieces for which special services have been elected. The postage value of Breast Cancer Research Semi-postal Stamps is fixed according to the First-Class Mail Non automation Single-Piece first-ounce letter rate in effect at the time of purchase; the postage value of Breast Cancer Research Semi-postal Stamps purchased before any subsequent change in the First-Class Mail Non automation Single-Piece first-ounce letter rate is unaffected by any subsequent change in that rate.
    c. Contributions to breast cancer research made through purchase of Breast Cancer Research stamps are not refundable. The postage value of Breast Cancer Research stamps for purposes of exchange or conversion under P014 is determined by the First-Class Mail Non automation Single-
Piece rate in effect at the time of purchase

 

Lycopene for Prostate Cancer – Research Summary

BACKGROUND: Harvard researchers reported in a 2002 article in the Journal of the National Cancer Institute that eating tomato products on a regular basis is associated with a reduced risk of prostate cancer. The research included more than 47,000 participants. Researchers then continued to follow the men for several more years to learn more about the specific foods that seem to protect men from prostate cancer. That research was published this year — also in the Journal of the National Cancer Institute. The study reports men who ate tomato sauce at least twice a week were about 20-percent less likely to develop prostate cancer when compared to men who rarely ate it.
CURRENT RESEARCH: Moffitt Cancer Center in Tampa, Florida is conducting a study to look at the mechanism by which lycopene actually stops the promotion of prostate cancer cells. For the study, men with cancer who are having their prostate surgically removed are participating. Generally, the men wait six weeks after diagnosis before they have the surgery. During the six-week period, each participant is given one of three doses of lycopene or a placebo. Researchers will then compare the cancer cells from the pre-surgical biopsy and to those after surgery to compare the cell growth. So far, more than 50 patients have participated. The preliminary results from this study are expected by the summer of 2004.
Advertisement
SUPPLEMENTS VS FOOD? Lycopene supplements are available on the market, but researchers say the supplements may not offer the same level of health protection. Experts point out that so far most studies have looked at intake of foods in the context of a whole diet. Therefore, including lycopene-rich foods is recommended over taking a supplement. LYCOPENE-RICH FOODS: The best way to include lycopene in your diet is to eat more processed tomato products. Research shows the body better absorbs lycopene when tomatoes are processed. While raw tomatoes have some lycopene, it takes more of them to make the processed foods, meaning there is more lycopene in each serving. Below is a list of foods and their lycopene content:
Lycopene Content in Foods (mg/100g)
Tomato Paste 42.2
Spaghetti Sauce 21.9
Chili Sauce 19.5
Tomato Ketchup 15.9
Tomato Juice 9.5
Pink Grapefruit 4.0
Raw Tomato 3.0

 

Armstrong Promotes Cancer Research

Associated Press

AUSTIN, Texas – With Lance Armstrong pushing for a record sixth consecutive Tour de France title this summer, his cancer research foundation is using the signature color of the world’s most grueling bicycle race for a new fund-raising campaign. The Lance Armstrong Foundation and Nike are promoting the sale of yellow wristbands engraved with the message, “Live Strong.”

“Yellow has taught me the true meaning of sacrifice. Yellow makes me suffer. Yellow is the reason I’m here,” Armstrong said. “Young people with cancer should be empowered to fight hard, dream big and live strong.”

The company will donate $1 million to the foundation, which hopes to raise an additional $5 million through wristband sales. Proceeds will go to the foundation for programs for young people with cancer. Foundation President Mitch Stoller said officials hope the wristbands will become as recognizable as the pink ribbons associated with breast cancer.

Armstrong overcame advanced testicular cancer that had spread to his lungs and brain. He went from having a 50 percent chance to live in 1996 to a string a five straight tour wins from 1999-2003, forever linking himself with the yellow jersey worn by the tour leader and champion.

 

Bush’s Trillion $ LIES About SS

WASHINGTON, Oct. 26 /PRNewswire/ — The Susan G. Komen Breast Cancer Foundation, credited as the nation’s leading catalyst in the fight against breast cancer, released today a non-partisan comparison of key health care proposals announced by Vice President Gore and Governor Bush in their quest for the Presidency.  The comparison is based on answers to a health care questionnaire designed by the Komen Foundation, to which both campaigns responded.  The Foundation hopes that the side-by-side analysis of the candidates’ varying proposals will assist voters in comparing and contrasting the approach each would take to important health care issues impacting women and families.

As a leader in the healthcare arena, the Susan G. Komen Breast Cancer Foundation has consistently promoted a broad range of issues impacting women and families.  The Komen Foundation, a bipartisan non-profit organization, works to educate women throughout the United States about the importance of these issues in their daily lives.

The Komen Foundation is an international organization with 114 domestic Affiliates in 45 states and the District of Columbia, as well as three Affiliates in Germany, Greece and Italy.  Since its inception, the Komen Foundation has raised more than $300 million to support breast cancer research, education, and screening and treatment programs.  These programs include cutting-edge basic, clinical and translational breast cancer research, and innovative outreach programs in local communities to assist the medically underserved.  The Susan G. Komen Breast Cancer Foundation is a nonpartisan charitable organization that does not endorse or oppose any candidate for public office